CompletedPhase 2NCT04177953
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
Studying Pleural mesothelioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Principal Investigator
- Rajiv Shah, MDThoraxklinik Heidelberg gGmbH, Medizinische Onkologie - Universitätsklinikum Heidelberg
- Intervention
- Carboplatin AUC 5(drug)
- Enrollment
- 92 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2025
Study locations (12)
- Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin, Berlin, Germany
- Klinikum Bremen Ost Pneumologie und Beatmungsmedizin, Bremen, Germany
- Studienzentrum der Thorachirurgischen und Pneumologischen Klinik Klinken der Stadt Köln gGmbH Krankenhaus Merheim, Cologne, Germany
- Ev. Kliniken Essen-Mitte, Klinik für Internistische Onkologie, Essen, Germany
- Universitätsklinikum Freiburg Klinik für Innere Medizin I, Freiburg im Breisgau, Germany
- Asklepios Fachklinik München-Gauting Thorakale Onkologie, Gauting, Germany
- LungenClinic Grosshansdorf, Großhansdorf, Germany
- Asklepios Klinikum Harburg, Klinik für Lungen-, Thorax und Atemwegserkrankungen, Harburg, Germany
- Thoraxklinik Heidelberg gGmbH, Medizinische Onkologie, Heidelberg, Germany
- Lungenklinik Hemer, Pneumologie und Thorakale Onkologie, Hemer, Germany
- Universitätsklinikum Regensburg, Thoraxchirurgie, Regensburg, Germany
- Robert-Bosch-Krankenhaus - Klinik Schillerhöhe, Onkologie, Stuttgart, Germany
Collaborators
Bristol-Myers Squibb · Thoraxklinik Heidelberg gGmbH - Universitätsklinikum Heidelberg
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04177953 on ClinicalTrials.govOther trials for Pleural mesothelioma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07192900Fast TILs to Treat Metastatic Cancer Patients With Pleural DiseaseDavid Bartlett, MD
- RECRUITINGNANCT07126509Partial Pleurectomy (Surgery) for Unresectable Pleural MesotheliomaUniversity of Chicago
- RECRUITINGPHASE1, PHASE2NCT07121374NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility StudyUniversity Hospital, Antwerp
- RECRUITINGPHASE1NCT06885697Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06840834Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and ChemotherapyIntergroupe Francophone de Cancerologie Thoracique
- RECRUITINGPHASE2NCT06875076Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural MesotheliomaThe First Hospital of Jilin University
- RECRUITINGPHASE2NCT06790082The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural MesotheliomaAalborg University Hospital
- RECRUITINGPHASE1NCT06566079Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid TumorsInSilico Medicine Hong Kong Limited